Skip to main content
. 2021 Feb 2;21(3):981. doi: 10.3390/s21030981

Table 4.

Demographic and clinical details of healthy control and patient with Parkinson disease.

Healthy Control Patient with PD
Age (Gender) Age (Gender) UPDRS (0–56) H & Y (1–5) Disease Duration (Years)
75(F) 62(F) 23 1.5 7
64(M) 66(F) 5 1.5 6
75(M) 72(F) 9 2 6
80(F) 73(F) 26 2 20
83(M) 78(M) 5 1 13
65(M) 65(M) 27 1 14
65(M) 79(F) 23 1 5
61(M) 69(F) 15 2 3
63(M) 80(M) 25 2 8
70(M) 81(M) 18 1.5 4
70(F) 60(F) 20 2 11
76(M) 80(F) 26 2 10
67(M) 65(F) 7 1 1
66(F) 75(M) 30 1 2
62(M) 72(F) 18 1 7
66(M) 63(F) 22 1.5 3
74(M) 66(F) 15 1.5 9
71(M) 83(F) 15 2.5 10
72(M) 75(F) 32 2.5 5
80(M) 69(F) 30 2.5 10
70.25(±6.307) 71.65(±6.872) 18.91(±7.831) 1.65(±0.526) 7.7(±4.495)